ARCHIVES

Risk Assessment Key In Long-Term Treatment

This article is from The Cancer Letter archive.

Vol. 31 No. 8 | August 29, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: Shingleton To Head AACI; Saunders To Get Two More Jobs At U. Texas Medical Branch

January 21, 1977

J&J, Amgen Settle Lawsuit Over ESAs As FDA Prepares Another Label Change.

July 18, 2008

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

Abortion, Miscarriage Don’t Increase Breast Cancer Risk, NCI Workshop Finds

March 7, 2003

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

April 25, 2014

In Brief: Byrd Heads ACS, Lee Clark President-Elect; NCI Needs Community Medical Oncologist

November 7, 1975